猪瘟病毒糖蛋白E0基因的克隆及及表达研究

用ＲＴ－ＰＣＲ方法扩增分别获得了中国猪瘟病毒强毒石门株和兔化弱毒株糖蛋白Ｅ０基因ｃＤＮＡ,并克隆到ｐＧＥＭ Ｔ载体中测定其核苷酸序列和推导出其对应氨基酸序列,结果表明这两个毒 间的Ｅ０基因核苷酸序列同源性为９５．３％,氨基酸序列同源性为９４％,有１４个殖基的差异;与几个代表毒株ＡＬＤ株、ＧＰＥ株、Ｂｒｅｓｃｉａ株、Ａｌｆｏｒｔ株和国外测得的兔化弱毒Ｃ株相应序列进行比较,所测石门病毒核苷酸序列与上述     

猪瘟病毒石门株与兔化弱毒株E0糖蛋白基因的克隆及序列分析

参考已发表的猪瘟病毒序列,设计并合成了一对引物,应用ＲＴＰＣＲ 技术,扩增了猪瘟兔化弱毒（Ｈｏｇ ｃｈｏｌｅｒａ ｖｉｒｕｓ ｌａｐｉｎｉｚｅｄ Ｃｈｉｎｅｓｅ ｓｔｒａｉｎ , ＨＣＬＶ） 和石门强毒株的Ｅ０ 糖蛋白基因,并将其克隆到ｐＧＥＭＴ 载体中,测定了其核苷酸序列,并推导了其氨基酸序列。结果表明我国这两株强弱不同毒株Ｅ０ 糖蛋白核苷酸序列同源性和推导的氨基酸序列同源性分别为９５－０ ％ 和９４－３ ％ ,有１３ 个氨基酸的差异,ＨＣＬＶ 比石门株多了一个潜在的Ｎ糖基化位点。将我国这两株病毒与国外已报导的ＨＣＶ 毒株Ｅ０ 基因序列进行了比较,发现石门株与日本的两株毒株ＡＬＤ 和ＧＰＥ－ 同源性较高,核苷酸序列同源性分别为９７－４ ％ 和９６－５ ％ ,氨基酸同源性分别为９７－４ ％ 和９６－０ ％ ,而与欧洲Ｂｒｅｓｃｉａ 株和Ａｌｆｏｒｔ 株同源性较低,核苷酸同源性分别为９２－２ ％ 和８６－５ ％ ,氨基酸同源性为９５－２ ％ 和９２－５ ％ , ＨＣＬＶ 与ＡＬＤ、ＧＰＥ－ 、Ｂｒｅｓｃｉａ、Ａｌｆｏｒｔ 株核苷酸同源性分别为９５－６ ％ 、９４－９ ％ 、９１－３ ％ 、８５－５ ％ …     

猪瘟病毒糖蛋白E0基因的克隆及其表达研究*

用ＲＴ－ＰＣＲＡ法扩增分别获得了中国猪瘟病毒强毒石门株和免化弱毒株糖蛋白Ｅ０基因ｃＤＮＡ,并克隆到ｐＧＥＭ Ｔ载体中测定其核着酸序列和推导出其对应氨基酸序列;结果表明这两个毒株间的Ｅ０基因核着酸序列同源性为９５．３％,氨基酸序列同源性为９４％,有１４个残基的差异;与几个代表毒株ＡＬＤ株、ＧＰＥ株、Ｂｒｅｓｃｉａ株、Ａｌｆｏｒｔ株和国外测得的免化弱毒Ｃ株相应序列进行比较,所测石门病毒核苷酸序列与上述各株对应序列的同源性分别为９８．０％、９７．１％、９２．７％、８６．８％和９５．４％;氨基酸序列同源性分别为９     

我国猪瘟病毒兔化弱毒株囊膜糖蛋白E0基因的克隆及序列测定

采用异硫氰酸胍一步法从４８０代猪瘟病毒兔化弱毒株（ＨＣＬＶ）脾毒中提取总ＲＮＡ,以该ＲＮＡ为模板,进行反转录,然后采用套式ＰＣＲ扩增出ＨＣＬＶ的囊膜糖蛋白Ｅ０基因,琼脂糖凝胶电泳表明其大小与预计相符。将扩增出的Ｅ０基因克隆到ｐＧＥＭＴ载体中,用自动序列分析仪对其进行序列测定。将测得的序列及推导的氨基酸序列与国外测得的Ｃ株相应序列进行比较,结果发现,它们之间核苷酸序列同源性为９９．０８％,氨基酸序列同源性为９８．４２％。     

汉滩病毒A9株强毒和弱毒克隆M基因片段G1糖蛋白编码区核苷酸序列的分析比较

采用逆转录－ＰＣＲ方法,用３对引物分３个片段扩增强毒克隆（Ａ９ｖ）及弱毒克隆（Ａ３％）的Ｍ基因片段ｃＤＮＡ,并克隆入ｐＧＥＭ－Ｔ载体中。采用Ｓａｎｇｅｒ双脱氧法测定了Ａ３９ｓ、Ａ９ｖ病毒Ｇ１糖蛋白编码区的全序列,发现二者均由１９７８个核苷酸组成,比７６／１１８株少６个核苷酸,并发现Ａ３９ｓ在Ｇ１编码区有３３个碱基及８个氨基酸与Ａ９ｖ不同。进一步与７６／１１８、ＨＶ１１４的相关序列比较,发现Ｇ１编码区的第６０６、６１４位氨基酸的变异同Ａ３９ｓ病毒的减毒有一定相关。从Ａ３９ｓ、Ａ９ｖ、７６／１１８及ＨＶ１１４４株病毒Ｇ１糖蛋白编码区推导的氨基酸序列亲疏水性资料显示,在位于Ｇ１糖蛋白Ｃ末端的最大亲水区域的６００～６２０位氨基酸区域,弱毒株Ａ３９ｓ同强毒株Ａ９ｖ、７６／１１８、ＨＶ１１４的亲水性有明显不同,而这一差异又主要由第６１４位氨基酸的变异所引起。因此推测,Ｇ１糖蛋白Ｃ端亲水区域同汉滩病毒毒力相关,而第６１４位的精氨酸被谷氨酰胺取代,同Ａ３９ｓ病毒毒力的减弱可能有关。     

猪瘟病毒石门株NS2—3基因片段的序列测定及比较

根据猪瘟病毒Ｃ株的序列,以计算机辅助设计,化学合成１对引物（ＰＦ５６４８／ＰＲ６６０４）,应用ＲＴＰＣＲ技术从感染猪血中成功地扩增了我国猪瘟病毒强毒石门株ＮＳ２３基因片段,大小为９５７ｂｐ,位于ＮＳ３基因的中部ＮＴＰａｓｅ和Ｈｅｌｉｃａｓｅ活性区。克隆后测序,结果表明该段基因产物具有解旋酶超家族全部七个特征性保守序列,包括共同的ＮＴＰ结合基序Ａ位点（ＧＸＧＫＴ／Ｓ）和Ｂ位点（３ｈｙ,２ｘ）Ｄ。序列同源性比较表明,石门株与日本的ＡＬＤ和ＧＰＥ－株同源性最高,与其它３株猪瘟病毒（Ｃ株、Ｂｒｅｓｃｉａ株和Ａｌｆｏｒｔ株）的同源性也很高,并与２株牛病毒性腹泻病毒（ＢＶＤＶ）（ＮＡＤＬ株和ＳＤ１株）也有较高的同源性,尤其是由核苷酸序列推导的氨基酸序列,同源性均大于９０％,是瘟病毒属基因组中最保守的区段,这与该基因产物在病毒复制及聚蛋白前体加工过程中所具有的重要功能是一致的     

RT-PCR和酶切方法区分猪瘟疫苗毒与野毒的研究

建立了套式RT-PCR与限制性内切酶酶切相结合的区别猪瘟兔化弱毒疫苗株与猪瘟病毒田间分离株的诊断方法。通过对猪瘟兔化弱毒疫苗株与猪瘟石门株E2基因主要抗原编码区序列进行限制性内切酶酶切位点分析,分别找出猪瘟兔化弱毒疫苗株与猪瘟石门株各自独有的限制性内切酶酶切位点,结果二者分别有10和16个独有的限制性内切酶的酶切位点;分别对17株猪瘟病毒E2基因主要抗原编码区序列进行这26个限制性内切酶酶切位点分析,结果表明有3个限制性内切酶（HgaI、Hin8I及Hsp92I）的酶切位点在HCLV株序列是独有的;利用HgaI限制性内切酶分别对HCLV、HCVSM及5株不同基因群的猪瘟病毒田间分离株进行酶切鉴定,结果只有HCLV株能够被HgaI酶切成2个片段,而其它的毒株则不能被切开。同时测定了套式RT-PCR方法的敏感性及特异性,结果其敏感性可达到0．2MLD,而对BDV以及BVDV均不能特异扩增。本方法的建立无疑对猪瘟在我国的控制和消灭具有重要的意义。     

RT-PCR和酶切方法区分猪瘟疫苗毒与野毒的研究*

建立了套式RT-PCR与限制性内切酶酶切相结合的区别猪瘟兔化弱毒疫苗株与猪瘟病毒田间分离株的诊断方法。通过对猪瘟兔化弱毒疫苗株与猪瘟石门株E2基因主要抗原编码区序列进行限制性内切酶酶切位点分析,分别找出猪瘟兔化弱毒疫苗株与猪瘟石门株各自独有的限制性内切酶酶切位点,结果二者分别有10和16个独有的限制性内切酶的酶切位点;分别对17株猪瘟病毒E2基因主要抗原编码区序列进行这26个限制性内切酶酶切位点分析,结果表明有3个限制性内切酶(HgaI、Hin8I及Hsp92I)     

猪瘟病毒石门强毒株和兔化弱毒疫苗株E2蛋白糖基化位点差异分析

猪瘟病毒强毒株和兔化弱毒疫苗株E2糖蛋白分别含有5个和6个潜在的糖基化位点,其中986N是兔化弱毒疫苗株所特有的。为了分析二者糖基化位点差异及其影响,将去掉信号肽和跨膜区的猪瘟病毒石门强毒株(Shi-men)和兔化弱毒疫苗株(HCLV)E2基因置于蜂素信号肽序列下游,使其在Sf9细胞内表达重组Shimen-E2和HCLV-E2蛋白。结果显示,重组E2蛋白以二聚体的形式分泌表达于细胞培养液中,但二者分子量存在差异。用endo H和PNGase F对纯化后的重组E2蛋白进行去糖基化处理后,二者分子量大小变成一致,证实石门强毒株和兔化弱毒株E2蛋白分子量大小的差异可能是由于糖基化程度的差异所致。对986N糖基化位点进行定点突变后发现,突变后的Shimen-E2与野生型HCLV-E2分子量大小一致,而突变后的HCLV-E2与野生型Shimen-E2分子量大小一致,表明Shimen-E2和HCLV-E2分子量大小的差异的确是由于986N糖基化位点的差异引起的。     

两个猪瘟病毒野毒株gp55基因抗原编码序列的分析及比较

利用反转录－ＰＣＲ方法扩增了吉林省猪瘟病毒（ＨＣＶ）两个野毒株ｇｐ５５基因的主要保护性抗原编码区,并将其克隆到ＰＧＥＭ＿Ｔ载体中,然后用Ｓａｎｇｅｒ双地测定了其核苷酸序列,并推导了其氨基酸序徇。将测定的这两个ＨＣＶ野毒株的部分序更与国内外已知的ＨＣＶ序列进行比较,结果表明：这两个野毒株的核苷酸序理的同生为９４．９％,氨基酸序列同源性为９７．４％,与１９８５－１９９２年意大利中部分离４个野毒的同源性     

猪瘟病毒强弱毒株和野毒株E2全基因序列测定及比较分析

为了比较猪瘟病毒 (HCV)野毒株、疫苗株及标准株之间E2基因抗原区域的差异 ,采用RT PCR扩增了HCV石门株、兔化弱毒疫苗株、野毒 0 3及 0 7株的囊膜糖蛋白E2 (gp55)全基因的cDNA片段 ,分别克隆于pGEM T载体中并对其进行了核苷酸序列测定及氨基酸序列的推导 ,同时进行了同源性比较及E2结构与功能的分析。所测 4株HCVE2基因的长度均为1 2 73bp,所编码的氨基酸序列均包括部分信号肽序列和完整的跨膜区序列 ,共由 381个氨基酸组成 ;4个毒株E2蛋白N末端的 683位至 690位信号肽序列 (WLLLVTGA)和C末端 1 0 30～1 0 63位跨膜区均为保守序列 ,而且具疏水性 ;N末端抗原功能区中 ,4个E2蛋白与其它所比较序列在位于第 753位至 759位氨基酸处 ,均有一段保守序列RYLASLH ,无一氨基酸发生变异 ,为亲水性 ,在整个E2蛋白抗原谱中抗原性峰值为最高 ,推测对抗原性产生起重要作用 ;4个E2蛋白的氨基酸序列中均含有 1 5个半胱氨酸 (Cys)残基 ,其数量及位置与国外五株HCV(Brescia ,C ,Alfort.ALD和GPE)完全一致。表明…     

12株猪瘟病毒E2基因主要抗原区域的序列差异分析

用RTPCR扩增了12个不同时期分离的HCV毒株E2基因主要抗原区域的cDNA片段并对其进行了序列测定。应用DNAstar序列分析软件对所测的12个HCV毒株与国内外已知的6个毒株Alfort株、Ald株、Brescia株、Gpe株、C株、CW株及早期已测定的HCLV株、HCVSM株和北京顺义株(BJSY2/96)3个毒株的相应片段进行了同源性比较分析。E2基因主要区域长度均为224 bp,包括从HCV 2485到2708位的E2基因B、C区域。所测的疫苗株HCLV与国外测得的疫苗株C株核苷酸及氨基酸同源性分别为991%和100%,表明目前应用的疫苗株是稳定的;用目前我国流行的部分野毒株对HCLV株免疫猪的攻击试验表明,HCLV对野毒株均具有很好的免疫力,这与序列分析结果相吻合。根据系统树分析,可将HCV分为两大群,5株90年代的野毒株及1株80年代的野毒株(其中北京3株、河南2株、广东1株)均与国内外C株、标准株属同一群(即第一群),其核苷酸及氨基酸的同源性分别为857%～100%和838%～100%;与Alfort株同属第二群的有6个野毒株(广西北海、辽宁、河北黄骅、吉林、深圳光明、四川成都),其中80年代与90年代的野毒株各有三株,核苷酸及氨基酸的同源性分别为843%～100%和851%～100%;21株HCV的核苷酸及氨基酸的同源性分别为781%～100%和784%～100%。两群之间的特征性差异表现在713和729位氨基酸位点的不同,经分析发现猪瘟野毒株具有复杂性与多样性。     

Primary structure of pilin protein from Bacteroides nodosus strain 216: comparison with the corresponding protein from strain 198

The amino acid sequence of pilin protein from Bacteroides nodosus strain 216 was determined. The protein had a calculated molecular weight of 15962 and contained the same number of amino acid residues (151) as the pilin from the previously sequenced strain 198. The sequence of the first 44 residues was common to both strains, including the unusual amino-terminal amino acid, N-methylphenylalanine. Of the remaining 107 residues, 37% of them differed between the two strains. Comparison of hydrophilicity profiles constructed from the sequence data indicated that a conserved region around residues 71-72 was probably the site of an antigenic determinant.     

猪瘟病毒兔化弱毒株cDNA片段的克隆及序列分析

猪瘟是猪最重要的传染病之一,往往给养猪业造成重大经济损失,猪瘟的病原为猪瘟病毒（ＨＣＶ）,属黄病毒科,瘟病毒属成员,其基因组为单股正链ＲＮＡ,长度为１２３ｋｂ,仅含有一个大的开放阅读框架,编码一个含３８９８个氨基酸残基（ＡＡ）的多聚前体蛋白［１,２］。目前已经定位的蛋白有５种,即Ｎｐｒｏ、Ｃ、Ｅ０、Ｅ１和Ｅ２,它们均由ＨＣＶＲＮＡ５′端所编码,除Ｎｐｒｏ外,其它４种均为ＨＣＶ的结构蛋白［３］。Ｎｐｒｏ为具有自我催化功能的蛋白水解酶,也是多聚蛋白Ｎ端的第一个蛋白水解酶,分子量为２３ｋＤ,Ｃ为构成…     

Gonococcal outer-membrane protein PIB: comparative sequence analysis and localization of epitopes which are recognized by type-specific and cross-reacting monoclonal antibodies.

Comparison of the inferred amino acid sequence of outer-membrane protein PIB from gonococcal strain P9 with those from other serovars reveals that sequence variations occur in two discrete regions of the molecule centred on residues 196 (Var1) and 237 (Var2). A series of peptides spanning the amino acid sequence of the protein were synthesized on solid-phase supports and reacted with a panel of monoclonal antibodies (mAbs) which recognize either type-specific or conserved antigenic determinants on PIB. Four type-specific mAbs reacted with overlapping peptides in Var1 between residues 192-198. Analysis of the effect of amino acid substitutions revealed that the mAb specificity is generated by differences in the effect of single amino acid changes on mAb binding, so that antigenic differences between strains are revealed by different patterns of reactivity within a panel of antibodies. The variable epitopes in Var1 recognized by the type-specific mAbs lie in a hydrophilic region of the protein exposed on the gonococcal surface, and are accessible to complement-mediated bactericidal lysis. In contrast, the epitope recognized by mAb SM198 is highly conserved but is not exposed in the native protein and the antibody is non-bactericidal. However, the conserved epitope recognized by mAb SM24 is centred on residues 198-199, close to Var1 , and is exposed for bactericidal killing.     

Amino acid sequence determination of protein biomarkers of Campylobacter upsaliensis and C. helveticus by "composite" sequence proteomic analysis

We have identified the protein biomarkers observed in the matrix-assisted laser desorption/ionization time-of-flight mass spectra (MALDI-TOF-MS) of cell lysates of five strains of Campylobacter upsaliensis and one strain of C. helveticus by "bottom-up" proteomic techniques. Only one C. upsaliensis strain had previously been genomically sequenced. The significant findings are as follows: (1) The protein biomarkers identified were: 10 kD chaperonin, protein of unknown function (DUF465), phnA protein, probable periplasmic protein, D-methionine-binding lipoprotein MetQ, cytochrome c family protein, DNA-binding protein HU, thioredoxin, asparigenase family protein, helix-turn-helix domain protein, as well as several ribosomal and conserved hypothetical proteins. (2) Amino acid substitutions in protein biomarkers across species and strains account for variations in biomarker ion mass-to-charge (m/z). (3) The most common post-translational modifications (PTMs) identified were cleavage of N-terminal methionine and N-terminal signal peptides. The rule that predicts N-terminal methionine cleavage, based on the penultimate residue, does not appear to apply to C. upsaliensis proteins when the penultimate residue is threonine. (4) It was discovered that some protein biomarker genes of the genomically sequenced C. upsaliensis strain were found to have nucleotide sequences with GTG or TTG "start" codons that were not the actual start codon (ATG) of the protein based on proteomic analysis. (5) Proteomic identification of the protein biomarkers of the non-genomically sequenced C. upsaliensis and C. helveticus strains involved identification of homologous protein amino acid sequences to that of the sequenced strain. Interestingly, some protein sequence regions that were not completely homologous to the sequenced strain, due to amino acid substitutions, were found to have homologous sequence regions from more phyogenetically distant species/strains, e.g., C. jejuni. Exploiting this partial homology of more distant species/strains, it was possible to construct a "composite" amino acid sequence using multiple non-overlapping sequence regions from both phylogenetically proximate and distant strains. The new composite sequence was confirmed by both MS and MS/MS data. Thus, it was possible in some cases to determine the amino acid sequence of an unknown protein biomarker from a genomically non-sequenced bacterial strain without the necessity of either genetically sequencing the biomarker gene or resorting to de novo MS/MS analysis of the full protein sequence.     

cDNA cloning, sequencing, expression and possible domain structure of human APEX nuclease homologous to Escherichia coli exonuclease III.

cDNA encoding the human homologue of mouse APEX nuclease was isolated from a human bone-marrow cDNA library by screening with cDNA for mouse APEX nuclease. The mouse enzyme has been shown to possess four enzymatic activities, i.e., apurinic/apyrimidinic endonuclease, 3'-5' exonuclease, DNA 3'-phosphatase and DNA 3' repair diesterase activities. The cDNA for human APEX nuclease was 1420 nucleotides long, consisting of a 5' terminal untranslated region of 205 nucleotide long, a coding region of 954 nucleotide long encoding 318 amino acid residues, a 3' terminal untranslated region of 261 nucleotide long, and a poly(A) tail. Determination of the N-terminal amino acid sequence of APEX nuclease purified from HeLa cells showed that the mature enzyme lacks the N-terminal methionine. The amino acid sequence of human APEX nuclease has 94% sequence identity with that of mouse APEX nuclease, and shows significant homologies to those of Escherichia coli exonuclease III and Streptococcus pneumoniae ExoA protein. The coding sequence of human APEX nuclease was cloned into the pUC18 SmaI site in the control frame of the lacZ promoter. The construct was introduced into BW2001 (xth-11, nfo-2) strain and BW9109 (delta xth) strain cells of E. coli. The transformed cells expressed a 36.4 kDa polypeptide (the 317 amino acid sequence of APEX nuclease headed by the N-terminal decapeptide derived from the part of pUC18 sequence), and were less sensitive to methylmethanesulfonate and tert-butyl-hydroperoxide than the parent cells. The N-terminal regions of the constructed protein and APEX nuclease were cleaved frequently during the extraction and purification processes of protein to produce the 31, 33 and 35 kDa C-terminal fragments showing priming activities for DNA polymerase on acid-depurinated DNA and bleomycin-damaged DNA. Formation of such enzymatically active fragments of APEX nuclease may be a cause of heterogeneity of purified preparations of mammalian AP endonucleases. Based on analyses of the deduced amino acid sequence and the active fragments of APEX nuclease, it is suggested that the enzyme is organized into two domains, a 6 kDa N-terminal domain having nuclear location signals and 29 kDa C-terminal, catalytic domain.     

The amino acid sequence of Acanthamoeba profilin

The complete amino acid sequence of Acanthamoeba profilin was determined by aligning tryptic, chymotryptic, thermolysin, and Staphylococcus aureus V8 protease peptides together with the partial NH2-terminal sequences of the tryptophan-cleavage products. Acanthamoeba profilin contains 125 amino acid residues, is NH2-terminally blocked, and has trimethyllysine at position 103. At five positions in the sequence two amino acids were identified indicating that the amoebae express at least two slightly different profilins. Charged residues are unevenly distributed, the NH2-terminal half being very hydrophobic and the COOH-terminal half being especially rich in basic residues. Comparison of the Acanthamoeba profilin sequence with that of calf spleen profilin (Nystrom, L. E., Lindberg, U., Kendrick-Jones, J., and Jakes, R. (1979) FEBS Lett. 101, 161-165) reveals homology in the NH2-terminal region. We suggest, therefore, that this region participates in the actin-binding activity.